Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists? - Wikidata - awgldk - TriplyDB

Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

http://www.wikidata.org/entity/Q37806693

about

Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome.Novel drug targets in clinical development for heart failure.Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Results of a meta-analysis of randomized controlled trials.Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure.Vasopressin receptor antagonists in patients with chronic heart failure.Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure.Hormone treatments in congestive heart failure.

P2860

Q28071921-D0BE676E-E0C8-4616-A3FF-866259926CC1 Q37171088-3E725D42-BAD0-4B14-96A9-F2365207244C Q38202895-0763E07F-55F2-4190-960C-809A455EDAA8 Q38570386-1A14F750-1DD3-4E29-9AA0-2A8AEAD996D3 Q38900417-454A4BC1-8D8D-4F62-95EE-567A52CCF5F4 Q38954498-696330D7-24B3-49BA-8013-CE3250360CC7 Q38965320-F1E43BEE-BA28-4D18-A4F5-0063D2A0CB05 Q55514382-D25DC18E-7648-4DED-920C-529DFFF2141A

P2860

Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

http://www.wikidata.org/entity/Q37806693

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@en

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@nl

type

label

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@en

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@nl

prefLabel

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@en

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@nl

P1433

Q37806693-360D77CE-A87F-44CF-BB15-C3E652D10981

P1476

Q37806693-129EC6DE-07C2-4EEC-9277-6CA8608B60E9

P2093

Q37806693-32616145-32FC-47E8-9169-D200A83172A1

Q37806693-60BAD7BB-FB22-46EB-BC50-6E8D4015BFE8

Q37806693-71279541-C833-4023-88F7-2B6DC97A3DD0

P2860

Q37806693-047261F7-ED77-48AB-BA1D-8442072EA6D6

Q37806693-05333EA8-E3A1-4BF6-BBD9-FE8A32506500

Q37806693-054BDB27-7EE8-4BBE-B165-CE934570D431

Q37806693-16EDC2D3-3DCE-4916-800A-80681DBC28CB

Q37806693-1BD1C632-ED8F-444E-AF18-C0642E415FD7

Q37806693-2039AB2D-5C1F-4171-9DAF-8B92D30E4E1C

Q37806693-300EF80A-60EC-4D43-9F61-E45723621EE5

Q37806693-3B721431-4678-4287-85A7-ED9A96886BBC

Q37806693-4243AAA3-C2F8-4DF6-8AC3-BEB0A68ADABD

Q37806693-44B05745-8E05-473A-8D23-C3E5C9D5DFB6

P304

Q37806693-7DE850B0-07CA-4E78-AEC8-4D82A3A0E012

P31

Q37806693-2051B986-740E-431B-879A-D9F0C9CDF2C3

P356

Q37806693-05104B58-D0A5-4D2A-9A84-6289130435F7

P433

Q37806693-1AA55C8C-CEAD-47CA-8AAA-ADC34726389E

P478

Q37806693-32BF6C92-09D5-4734-8646-A7FE04BF7D7A

P577

Q37806693-262EAEBD-DF78-4B3A-ACCB-DEA2D5129FD1

P698

Q37806693-039E3C4B-256A-41D4-9A1D-4DB105D05EA5

P921

Q37806693-245bd01b-f08a-45bd-9385-988ed148d129

Q37806693-6E92FE7B-6F69-4967-B47F-65BF0C22B949

Q37806693-FA97D3E7-3738-4C3D-95B8-19F431D64BDF

P356

S11897-010-0035-3

P1433

Current heart failure reports

P1476

Targeting hyponatremia and hem ...... e for vasopressin antagonists?

@en

P2093

Gregory Valania

http://www.w3.org/2001/XMLSchema#string

Manmeet Singh

http://www.w3.org/2001/XMLSchema#string

Mara T Slawsky

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Hormones and hemodynamics in heart failure.

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

Vasopressin: a new target for the treatment of heart failure.

P304

198-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-010-0035-3

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21046492

http://www.w3.org/2001/XMLSchema#string

P921